Our Products

Our translation-friendly bone marrow– and adipose-derived hMSCs are offered in a variety of formats, including individual vials (RoosterVial™, RoosterRTP™), working cell banks (RoosterBank™), and kits (RoosterKit™) to simplify and streamline donor selection and use.  Our hMSCs are designed for scale-up process development, and will quickly and efficiently get you to billions of cells to accelerate your bioprocess R&D.  Each vial of cells is guaranteed to expand 10-fold within 1 week when paired with our bioprocess media systems.

Our high-performance bioprocess media systems are the only products specifically engineered for scalable MSC expansion. These rich media formulations contain a proprietary mixture of growth factors and cytokines that are known mitogens for hMSCs.  Our bioprocess media systems are designed for batch (2D) and fed-batch (3D) culture processes – nourishing and replenishing for rapid proliferation, so that cell volumes are realized quickly, efficiently and reproducibly. Only 1/6th of the traditional media requirement is needed to generate cells for experiments.

Rapidly and economically screen multiple hMSC donors with our Donor Screening Kit. Get set up in a bioreactor or start bioprinting MSCs. When you bundle our cell and bioprocess media systems, you are fit to a product format that's right for you. We work with you to accelerate your product development and path to the clinic, all while saving you time and money.

Gain control of your clinical pipeline by unlocking your adult hMSC manufacturing process. CliniControl (CC) bone marrow-derived hMSCs and paired, highly-productive, bioprocess media systems are manufactured under cGMP and available to our customers that are aggressively moving towards clinical translation of hMSC-based therapeutics. RoosterVial™-hBM-20M-CC and RoosterNourish™-MSC-CC are manufacturing starting and ancillary materials for your cell manufacturing process supported by Quality documentation and FDA Master Files to reduce Regulatory burden. CliniControl cell and bioprocess media systems robustly and reproducibly get you to clinically-relevant lot sizes while simplifying and de-risking your supply chain.

Prevent the need for a costly and time-intensive hMSC supply chain. Bypass major steps in clinical manufacturing and accelerate through clinical translation with a commercially-viable product platform.